Earkart to Incorporate Two Wholly Owned Subsidiaries

Earkart Ltd has announced the incorporation of two wholly-owned subsidiaries, Earkart Pharmaceuticals Private Limited and Earkart Healthcare Services Private Limited. The decision was approved during a board meeting held on May 29, 2026. Each subsidiary will have a proposed authorized and paid-up share capital of ₹1,00,000. Earkart Pharmaceuticals will focus on manufacturing and distributing pharmaceuticals, while Earkart Healthcare Services will provide services in the healthcare sector. The incorporation is a related party transaction, with the parent company subscribing to 100% of the initial paid-up capital in cash at face value of ₹10 per share.